It looks like the final round of Emergent's AstraZeneca Covid-19 doses have been released

Four more batches of AstraZeneca’s Covid-19 vaccine that were made at Emergent BioSolutions’ Baltimore plant have been cleared for shipment outside the US by the FDA, but it seems like this will be the last round of updates the agency is providing in connection to the quarantined doses from the CDMO, wrapping up a nearly one-year saga that led to the tossing of millions of Covid-19 doses.